Trial · NCT03203850
Results by group132
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 132
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Patients Achieving Target SF ≤ 100 μg/L for the First Time | Deferasirox FCT 7mg/kg | Responder | 40 | 95% Confidence Interval 22.7 to 59.4 | percentage of participants |
| Proportion of Patients Achieving Target SF ≤ 100 μg/L for the First Time | Phlebotomy | Responder | 80 | 95% Confidence Interval 51.9 to 95.7 | percentage of participants |
| Proportion of Patients Achieving Target SF ≤ 100 μg/L for the First Time | Deferasirox FCT 7mg/kg | Non-Responder | 60 | 95% Confidence Interval 40.6 to 77.3 | percentage of participants |
| Proportion of Patients Achieving Target SF ≤ 100 μg/L for the First Time | Phlebotomy | Non-Responder | 20 | 95% Confidence Interval 4.3 to 48.1 | percentage of participants |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) | Deferasirox FCT 7mg/kg | At least one ocular AE | 9 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) | Phlebotomy | At least one ocular AE | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) | Deferasirox FCT 7mg/kg | Treatment-related ocular AEs | 2 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) | Phlebotomy | Treatment-related ocular AEs | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Deferasirox FCT 7mg/kg | Cataract nuclear | 2 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Phlebotomy | Cataract nuclear | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Deferasirox FCT 7mg/kg | Glaucoma | 2 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Phlebotomy | Glaucoma | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Deferasirox FCT 7mg/kg | Blepharitis | 1 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Phlebotomy | Blepharitis | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Deferasirox FCT 7mg/kg | Cellulitis orbital | 1 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Phlebotomy | Cellulitis orbital | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Deferasirox FCT 7mg/kg | Dry eye | 1 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Phlebotomy | Dry eye | 0 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Deferasirox FCT 7mg/kg | Eye pain | 1 | Participants | |
| Number of Participants With Ocular Treatment Emergent Adverse Events (AEs) by Preferred Term | Phlebotomy | Eye pain | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03203850/results